• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国北京成人 COVID-19 患者病毒持续清除的危险因素:一项前瞻性观察研究。

Risk factors for prolonged viral clearance in adult patients with COVID-19 in Beijing, China: A prospective observational study.

机构信息

Department of Cardiology, 5th Center of Chinese PLA General Hospital, Beijing 100071, China.

Department of Respiratory and Critical Care Diseases, 5th Center of Chinese PLA General Hospital, Beijing 100071, China.

出版信息

Int Immunopharmacol. 2020 Dec;89(Pt A):107031. doi: 10.1016/j.intimp.2020.107031. Epub 2020 Sep 23.

DOI:10.1016/j.intimp.2020.107031
PMID:33039964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7510442/
Abstract

Clearance of COVID-19 from the human body has not been established. Our study collected the laboratory test results from patients and analyzed the correlation between early changes in serum indices and the virus clearance by univariable and multivariable COX regression models, with an aim to explore the risk factors for prolonged viral clearance. The study included 61 patients with COVID-19 treated at the Fifth Medical Center of PLA General Hospital in Beijing from 20 January 2020 to 20 February 2020. We set the total observation of the disease course to 20 days and the patients were divided into two groups (prolonged group, > 20d vs. normal group, ≤ 20d). The 48 patients with COVID-19 included in this study, 13 remained positive for viral nucleic acid monitoring 20 days after onset. The median for virus clearance was 16 days (range, 6-35 days). The results showed that hypertension, a lactate dehydrogenase level > 211.5 U/L, an interleukin 6 (IL-6) level > 12.5 pg/ml, and a NK lymphocyte percentage > 0.5% were associated with prolonged viral clearance. Therefore, we showed that a history of hypertension, an elevated IL-6 level, and an elevated percentage of NK cells were risk factors for prolonged viral clearance.

摘要

尚未确定 COVID-19 从人体中的清除情况。我们的研究收集了患者的实验室检测结果,并通过单变量和多变量 COX 回归模型分析了血清指标早期变化与病毒清除之间的相关性,旨在探讨延长病毒清除时间的危险因素。该研究纳入了 2020 年 1 月 20 日至 2 月 20 日期间在北京解放军总医院第五医疗中心治疗的 61 例 COVID-19 患者。我们将疾病总观察期设定为 20 天,并将患者分为两组(延长组,>20d 与正常组,≤20d)。本研究中纳入的 48 例 COVID-19 患者中,有 13 例在发病后 20 天仍监测到病毒核酸阳性。病毒清除的中位数为 16 天(范围,6-35 天)。结果表明,高血压、乳酸脱氢酶水平>211.5 U/L、白细胞介素 6(IL-6)水平>12.5 pg/ml 和 NK 淋巴细胞百分比>0.5%与延长病毒清除有关。因此,我们表明高血压病史、IL-6 水平升高和 NK 细胞百分比升高是延长病毒清除时间的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a9/7510442/f9767805dfda/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a9/7510442/e3174d096cdc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a9/7510442/f9767805dfda/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a9/7510442/e3174d096cdc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a9/7510442/f9767805dfda/gr2_lrg.jpg

相似文献

1
Risk factors for prolonged viral clearance in adult patients with COVID-19 in Beijing, China: A prospective observational study.中国北京成人 COVID-19 患者病毒持续清除的危险因素:一项前瞻性观察研究。
Int Immunopharmacol. 2020 Dec;89(Pt A):107031. doi: 10.1016/j.intimp.2020.107031. Epub 2020 Sep 23.
2
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital.在一家意大利参考医院收治的大量 COVID-19 患者的上呼吸道标本中,病毒 RNA 持续排出的风险和预测因素。
Int J Infect Dis. 2021 Apr;105:532-539. doi: 10.1016/j.ijid.2021.02.117. Epub 2021 Mar 3.
3
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.COVID-19 患者中 SARS-CoV-2 病毒持续排出与阿比多尔治疗开始延迟和就诊时间推迟有关:一项回顾性队列研究。
Curr Med Sci. 2021 Dec;41(6):1096-1104. doi: 10.1007/s11596-021-2434-y. Epub 2021 Sep 13.
4
Impact of age on duration of viral RNA shedding in patients with COVID-19.年龄对新型冠状病毒肺炎患者病毒RNA脱落持续时间的影响。
Aging (Albany NY). 2020 Nov 20;12(22):22399-22404. doi: 10.18632/aging.104114.
5
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.免疫功能低下患者中 SARS-CoV-2 的病毒持续排出。
J Infect Chemother. 2021 Feb;27(2):387-389. doi: 10.1016/j.jiac.2020.12.001. Epub 2020 Dec 4.
6
Elevated Exhaustion Levels of NK and CD8 T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.NK 和 CD8 T 细胞衰竭水平升高可作为 COVID-19 疾病进展和预后的指标。
Front Immunol. 2020 Oct 14;11:580237. doi: 10.3389/fimmu.2020.580237. eCollection 2020.
7
High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients.高密度脂蛋白胆固醇作为影响 COVID-19 患者病毒清除的一个因素。
Respir Med. 2020 Dec;175:106218. doi: 10.1016/j.rmed.2020.106218. Epub 2020 Nov 7.
8
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.促炎细胞因子与 COVID-19 患者病毒 RNA 持续脱落有关。
Clin Immunol. 2020 Dec;221:108611. doi: 10.1016/j.clim.2020.108611. Epub 2020 Oct 14.
9
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection.住院的 SARS-CoV-2 感染患者病毒 RNA 持续脱落的决定因素。
Diagn Microbiol Infect Dis. 2021 Jun;100(2):115347. doi: 10.1016/j.diagmicrobio.2021.115347. Epub 2021 Feb 12.
10
Factors associated with prolonged duration of viral clearance in non-severe SARS-CoV-2 patients in Osaka, Japan.与日本大阪非重症 SARS-CoV-2 患者病毒清除时间延长相关的因素。
Environ Health Prev Med. 2021 Dec 6;26(1):115. doi: 10.1186/s12199-021-01035-y.

引用本文的文献

1
Demographic and clinical factors affecting serum IL-6, and its correlation with the severity, and mortality of COVID-19.影响血清白细胞介素-6的人口统计学和临床因素及其与新型冠状病毒肺炎严重程度和死亡率的相关性。
Med Microecol. 2022 Dec;14:100068. doi: 10.1016/j.medmic.2022.100068. Epub 2022 Nov 19.
2
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance.住院 COVID-19 患者病毒清除的免疫决定因素:循环中幼稚 CD4+T 细胞计数减少与病毒清除延迟相对应。
Cells. 2022 Sep 2;11(17):2743. doi: 10.3390/cells11172743.
3
Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients.

本文引用的文献

1
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.新型冠状病毒肺炎外周血淋巴细胞亚群特征变化。
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
2
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征:回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
3
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection.新型冠状病毒感染中病毒清除的时间动力学及症状消退情况
新冠康复患者中SARS-CoV-2中和抗体反应的轨迹模式
Commun Med (Lond). 2022 May 19;2:53. doi: 10.1038/s43856-022-00119-2. eCollection 2022.
4
Prolonged SARS-CoV-2 nucleic acid conversion time in military personnel outbreaks with presence of specific IgG antibodies.特定 IgG 抗体存在时军人暴发的 SARS-CoV-2 核酸转换时间延长。
J Med Microbiol. 2022 Jan;71(1). doi: 10.1099/jmm.0.001498.
5
The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.菲律宾 CORONA 研究中糖尿病患者的结局。
Sci Rep. 2021 Dec 24;11(1):24436. doi: 10.1038/s41598-021-03898-1.
6
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.细胞因子风暴和I型干扰素反应在新冠病毒疾病发病机制中的关键决定因素
Clin Microbiol Rev. 2021 May 12;34(3). doi: 10.1128/CMR.00299-20. Print 2021 Jun 16.
7
Serum Prealbumin Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis.血清前白蛋白浓度、新冠病毒疾病严重程度与死亡率:一项系统评价与荟萃分析
Front Med (Lausanne). 2021 Jan 26;8:638529. doi: 10.3389/fmed.2021.638529. eCollection 2021.
Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152. doi: 10.1164/rccm.202003-0524LE.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.源自中国武汉的新型冠状病毒:全球卫生治理面临的挑战
JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097.
9
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.中东呼吸综合征冠状病毒(MERS-CoV):冠状病毒研究小组声明
J Virol. 2013 Jul;87(14):7790-2. doi: 10.1128/JVI.01244-13. Epub 2013 May 15.
10
Characterization of age-related changes in natural killer cells during primary influenza infection in mice.小鼠初次流感感染期间自然杀伤细胞与年龄相关变化的特征分析
Mech Ageing Dev. 2008 Apr;129(4):223-30. doi: 10.1016/j.mad.2008.01.003. Epub 2008 Jan 20.